Skip to main content
. 2026 Sep 11;16:35. doi: 10.25259/JCIS_42_2026

Table 2:

Intraprocedural findings of endovascular treatment modalities and access sites.

Variables RA+DCB (n=50) DCB (n=53) p-value Popliteal (n=46) Femoral (n=57) p-value
Lesion characteristics
Right SFA (%) 23 (46) 27 (50.9) 0.62 22 (47.8) 28 (49.1) 0.62
Length, cm 15.65±7.43 12.63±9.23 0.07 18.70±7.05 10.38±7.76 0.001
Proximal diameter, mm 4.56±1.00 4.85±0.96 0.14 4.98±0.96 4.49±0.96 0.03
Distal diameter, mm 4.28±0.99 4.09±0.89 0.26 4.27±1.07 4.01±0.92 0.05
TASC-II (%)
  Type A 5 (10) 12 (22.6) 0.05 3 (6.5) 14 (24.6) 0.001
  Type B 12 (24) 20 (37.7) 4 (8.7) 28 (49.1)
  Type C 16 (32) 9 (17) 18 (39.1) 7 (12.3)
  Type D 17 (34) 12 (22.6) 21 (47.5) 8 (14)
PACSS Score (≥3) (%) 11 (22) 16 (30.2) 0.35 9 (19.6) 18 (31.6) 0.17
Kockelkoren score (<7) (%) 41 (82) 41 (77.4) 0.56 36 (78.3) 46 (80.7) 0.76
Intraprocedural (%)
  Access*/Atherectomy 26 (52) 20 (37.7) 0.15 26 (56.5) 24 (42.1) 0.15
  Dissection 42 (84) 39 (73.6) 0.20 39 (84.8) 42 (73.7) 0.17
DISFORM* (%)
  Group A 27 (64.3) 25 (64.1) 0.98 24 (61.5) 28 (66.7) 0.63
  Group B 15 (35.7) 14 (35.9) 15 (38.5) 14 (33.3)
Bailout Stenting (%) 5 (10) 4 (7.5) 0.74 2 (3.5) 7 (15.2) 0.07
Distal Embolization (%) 3 (6) 0 (0) 0.11 1 (1.8) 2 (4.3) 0.59
*

Femoral puncture is including cross procedures, *DISFORM: Diameter reduction, spiral shape, flow impairment, or adverse morphology, TASC: Trans-Atlantic Inter-Society Consensus, PACSS: The peripheral artery calcification scoring system, Kockelkoren Score; <7 intimal dominant, ≥7 non-intimal dominant plaque formation. SFA: Superficial femoral artery, CTO: Chronic total occlusion, RA: Rotational atherectomy, DCB: Drug coated balloon, Statistical significance was defined as p < 0.05. Continuous variables are presented as mean ± standard deviation